KVUE:NYSE
Kenvue Inc
$ 17.74
arrow_upward
+0.20%(+0.035) 1D
10-р сарын 12, 14:23:14 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KVUE...
Open
$ 17.66
High
$ 17.74
Low
$ 17.48
Mkt. cap
34.06 тэрбум
Avg. vol.
23.91 сая
Volume
10.68 сая
Dividend
4.74%
Quarterly dividend
$ 0.21
Ex-dividend date
2026 оны 9-р сарын 21
P/E ratio
20.56
52-wk high
$ 20.13
52-wk low
$ 14.02
EPS
$ 0.86
Beta
0.48
Shares outstanding
1.92 тэрбум
No. of employees
22 мян
Open
$ 17.66
High
$ 17.74
Low
$ 17.48
Mkt. cap
34.06 тэрбум
Avg. vol.
23.91 сая
Volume
10.68 сая
Dividend
4.74%
Quarterly dividend
$ 0.21
Ex-dividend date
2026 оны 9-р сарын 21
P/E ratio
20.56
52-wk high
$ 20.13
52-wk low
$ 14.02
EPS
$ 0.86
Beta
0.48
Shares outstanding
1.92 тэрбум
No. of employees
22 мян
News stories
From web sources and news partners
Investing.com Nigeria
·
1 өдрийн өмнө
Form 4 Kenvue Inc For: 11 October By Investing.com
Profile
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
About Kenvue Inc
CEOKirk Perry
Employees21.9 мян
Founded2022
HeadquartersSummit, Нью Жерси, Америкийн Нэгдсэн Улс
SectorPersonal care products
Websitekenvue.com